MILPITAS, Calif., Oct. 2, 2024
/PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the
"Company") (NYSE: ZEPP), a global leader in smart wearables and
health technology, today announced that it has received a letter
from the New York Stock Exchange ("NYSE") dated October 2, 2024 (the "October Letter"), notifying
the Company that it has regained compliance with the NYSE's
continued listing criterion of a minimum share price as set forth
in Section 802.01C of the NYSE Listed Company Manual (the "NYSE
Minimum Price Continued Listing Criterion").
As previously announced, the Company received a letter from the
NYSE dated April 30, 2024, notifying
the Company that it was below compliance standards due to the
average closing price of the Company's American depositary shares
being less than $1.00 for a
consecutive 30 trading-day period. Following the receipt of the
October Letter, the Company is no longer considered below the NYSE
Minimum Price Continued Listing Criterion and has regained
compliance regarding this matter.
About Zepp Health Corporation
Zepp Health (NYSE: ZEPP), a global smart wearable and health
technology leader, empowers users to live their healthiest lives
through its leading consumer brands, including Amazfit,
Zepp Clarity, and Zepp Aura.
Leveraging its proprietary Zepp Digital Health Management Platform,
Zepp Health delivers actionable insights and guidance to users
worldwide. With a presence in over 90 countries and a robust
ecosystem of products and services, Zepp Health is at the forefront
of advancing wearable intelligence and digital health
technology.
For more information on Zepp Health and its products, please
visit www.zepp.com
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the U.S.
Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
"will," "expects," "anticipates," "future," "intends," "plans,"
"believes," "estimates," "confident" and similar statements.
Statements that are not historical facts, including statements
about the Company's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and
uncertainties. A number of factors could cause actual results to
differ materially from those contained in any forward-looking
statement, including but not limited to the following: the
cooperation with Xiaomi, the recognition of the Company's
self-branded products; the Company's growth strategies; trends and
competition in global wearable technology market; changes in the
Company's revenues and certain cost or expense accounting policies;
governmental policies relating to the Company's industry and
general economic conditions in China and the global. Further information
regarding these and other risks is included in the Company's
filings with the United States Securities and Exchange Commission.
All information provided in this press release and in the
attachments is as of the date of this press release, and the
Company undertakes no obligation to update any forward-looking
statement, except as required under applicable law.
For investor and media inquiries, please contact:
Zepp Health Corporation
Grace Yujia Zhang
Email: ir@zepp.com
Piacente Financial Communications
Email: zepp@tpg-ir.com
View original
content:https://www.prnewswire.com/news-releases/zepp-regains-compliance-with-nyse-minimum-price-continued-listing-criterion-302265308.html
SOURCE Zepp Health Corp.